Third quarter sales rise 5% at Horizon buyer Amgen
Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, has said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.
Business
• 31 Oct 23
